<?xml version="1.0" encoding="UTF-8"?>
<p>HIV prevention measures have lagged markedly in the RF. This has been particularly true for the large population of PWID, since evidence-based drug treatment for opioid dependence is not available [
 <xref rid="pmed.1002462.ref020" ref-type="bibr">20</xref>,
 <xref rid="pmed.1002462.ref021" ref-type="bibr">21</xref>]. The RF continues to ban any opioid agonist therapy, including prescription use of methadone and buprenorphine, despite these agents being on WHO’s essential drug list [
 <xref rid="pmed.1002462.ref021" ref-type="bibr">21</xref>–
 <xref rid="pmed.1002462.ref023" ref-type="bibr">23</xref>].
</p>
